Financials

  • Market Capitalization 487.4 M
  • Employee 48
  • Founded 2020
  • CEO N/A
  • Website www.evommune.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y79N887
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-1.53
Índice preço/fluxo de caixa
8.08

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
2915
PRLD
Prelude Therapeutics Incorporated - Common Stock
6.34 USD-3.35%-3.35%+36.64%+391.47%505.95 M USD
2918
CCCC
C4 Therapeutics, Inc. - Common Stock
4.10 USD-3.30%0.00%+18.84%+62.06%504.40 M USD
2948
RLMD
Relmada Therapeutics, Inc. - Common Stock
4.52 USD-0.66%-3.42%-13.58%+444.58%482.15 M USD
2956
RZLT
Rezolute, Inc. - Common Stock
4.98 USD-1.19%+6.18%+1.01%-31.69%479.54 M USD